Toggle Main Menu Toggle Search

Open Access padlockePrints

Dystrophin quantification Biological and translational research implications

Lookup NU author(s): Dr Rita Barresi, Dr Steven Laval, Professor Volker StraubORCiD


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Objective:We formed a multi-institution collaboration in order to compare dystrophin quantification methods, reach a consensus on the most reliable method, and report its biological significance in the context of clinical trials.Methods:Five laboratories with expertise in dystrophin quantification performed a data-driven comparative analysis of a single reference set of normal and dystrophinopathy muscle biopsies using quantitative immunohistochemistry and Western blotting. We developed standardized protocols and assessed inter- and intralaboratory variability over a wide range of dystrophin expression levels.Results:Results from the different laboratories were highly concordant with minimal inter- and intralaboratory variability, particularly with quantitative immunohistochemistry. There was a good level of agreement between data generated by immunohistochemistry and Western blotting, although immunohistochemistry was more sensitive. Furthermore, mean dystrophin levels determined by alternative quantitative immunohistochemistry methods were highly comparable.Conclusions:Considering the biological function of dystrophin at the sarcolemma, our data indicate that the combined use of quantitative immunohistochemistry and Western blotting are reliable biochemical outcome measures for Duchenne muscular dystrophy clinical trials, and that standardized protocols can be comparable between competent laboratories. The methodology validated in our study will facilitate the development of experimental therapies focused on dystrophin production and their regulatory approval.

Publication metadata

Author(s): Anthony K, Arechavala-Gomeza V, Taylor LE, Vulin A, Kaminoh Y, Torelli S, Feng L, Janghra N, Bonne G, Beuvin M, Barresi R, Henderson M, Laval S, Lourbakos A, Campion G, Straub V, Voit T, Sewry CA, Morgan JE, Flanigan KM, Muntoni F

Publication type: Article

Publication status: Published

Journal: Neurology

Year: 2014

Volume: 83

Issue: 22

Pages: 2062-2069

Print publication date: 25/11/2014

Online publication date: 29/10/2014

Acceptance date: 02/09/2014

ISSN (print): 0028-3878

ISSN (electronic): 1526-632X

Publisher: Lippincott Williams & Wilkins


DOI: 10.1212/WNL.0000000000001025


Altmetrics provided by Altmetric


Funder referenceFunder name
Association Francaise contre les Myopathies (AFM)
University College London
Wellcome Trust University Award
Great Ormond Street Hospital Children's Charity
National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust
TREAT-NMD Neuromuscular Network
305370European Union's seventh framework programme (FP7) under SKIP-NMD grant
HICF-1009-025Wellcome Trust
R01 NS043264National Institute of Neurological Diseases and Stroke